Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Febe van Maldegem

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The Journal of Pathology|December 19, 2009
Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaquesOnno J de Boer, Jelger J van der Meer, Peter Teeling, et al.
Haematologica|July 5, 2006
Antigen receptors and somatic hypermutation in B-cell chronic lymphocytic leukemia with Richter's transformationLaura A Smit, Febe van Maldegem, Anton W Langerak, et al.
Science Translational Medicine|September 20, 2019
Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancerMiriam Molina-Arcas, Christopher Moore, Sareena Rana, et al.
Science Advances|July 20, 2022
Therapeutic KRAS<sup>G12C</sup> inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancersEdurne Mugarza, Febe van Maldegem, Jesse Boumelha, et al.
Journal for Immunotherapy of Cancer|November 28, 2025
Immune-modulating effects on tumor-draining lymph nodes of neoadjuvant chemoradiotherapy combined with dual immunotherapy in patients with T3-4N0-2 NSCLCEzgi B Ulas, Sofie J I Koomen, Anne Vrijmoet, et al.
Nature Communications|October 9, 2021
Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometryFebe van Maldegem, Karishma Valand, Megan Cole, et al.
Nature Communications|July 6, 2026
Statescope: an integrative deconvolution framework for discovering cell states in tumorsJurriaan Janssen, Mischa F B Steketee, Aryamaan Bose, et al.
Nature Communications|June 15, 2024
Deep cell phenotyping and spatial analysis of multiplexed imaging with TRACERx-PHLEXAlastair Magness, Emma Colliver, Katey S S Enfield, et al.
Science Advances|November 1, 2024
Spatial multiplex analysis of lung cancer reveals that regulatory T cells attenuate KRAS-G12C inhibitor-induced immune responsesMegan Cole, Panayiotis Anastasiou, Claudia Lee, et al.
Journal for Immunotherapy of Cancer|September 30, 2024
Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: the INCREASE studyIdris Bahce, Chris Dickhoff, Famke L Schneiders, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Journal of Pathology|December 19, 2009
Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaquesOnno J de Boer, Jelger J van der Meer, Peter Teeling, et al.
Haematologica|July 5, 2006
Antigen receptors and somatic hypermutation in B-cell chronic lymphocytic leukemia with Richter's transformationLaura A Smit, Febe van Maldegem, Anton W Langerak, et al.
Science Translational Medicine|September 20, 2019
Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancerMiriam Molina-Arcas, Christopher Moore, Sareena Rana, et al.
Science Advances|July 20, 2022
Therapeutic KRAS<sup>G12C</sup> inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancersEdurne Mugarza, Febe van Maldegem, Jesse Boumelha, et al.
Journal for Immunotherapy of Cancer|November 28, 2025
Immune-modulating effects on tumor-draining lymph nodes of neoadjuvant chemoradiotherapy combined with dual immunotherapy in patients with T3-4N0-2 NSCLCEzgi B Ulas, Sofie J I Koomen, Anne Vrijmoet, et al.
Nature Communications|October 9, 2021
Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometryFebe van Maldegem, Karishma Valand, Megan Cole, et al.
Nature Communications|July 6, 2026
Statescope: an integrative deconvolution framework for discovering cell states in tumorsJurriaan Janssen, Mischa F B Steketee, Aryamaan Bose, et al.
Nature Communications|June 15, 2024
Deep cell phenotyping and spatial analysis of multiplexed imaging with TRACERx-PHLEXAlastair Magness, Emma Colliver, Katey S S Enfield, et al.
Science Advances|November 1, 2024
Spatial multiplex analysis of lung cancer reveals that regulatory T cells attenuate KRAS-G12C inhibitor-induced immune responsesMegan Cole, Panayiotis Anastasiou, Claudia Lee, et al.
Journal for Immunotherapy of Cancer|September 30, 2024
Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: the INCREASE studyIdris Bahce, Chris Dickhoff, Famke L Schneiders, et al.
Pageof 3